(AKRO) Akero Therapeutics - Performance 107.6% in 12m
AKRO performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
34.02%
#13 in Peer-Group
Rel. Strength
94.43%
#428 in Stock-Universe
Total Return 12m
107.61%
#11 in Peer-Group
Total Return 5y
40.14%
#25 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 57.56 USD |
| 52 Week Low | 21.87 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 33.03 |
| Buy/Sell Signal +-5 | 0.01 |
| Support / Resistance | Levels |
|---|---|
| Support | 49.0, 45.4, 34.0, 30.5, 27.7 |
| Resistance |
12m Total Return: AKRO (107.6%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: AKRO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AKRO
| Total Return (including Dividends) | AKRO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -2.62% | 3.15% | 4.01% |
| 3 Months | 44.60% | 17.08% | 17.14% |
| 12 Months | 107.61% | -11.14% | 13.46% |
| 5 Years | 40.14% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | AKRO | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -65.2% | 52.1% | 90.3% |
| 3 Months | 84% | 79.4% | 97.5% |
| 12 Months | 81.7% | -87.4% | 46.4% |
| 5 Years | 22.9% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th41.50 | -5.59% | -6.37% |
| 3 Month | %th75.50 | 23.50% | 23.44% |
| 12 Month | %th95.00 | 133.63% | 82.98% |
| 5 Years | %th88.50 | 79.56% | -34.13% |
FAQs
Does Akero Therapeutics (AKRO) outperform the market?
Yes,
over the last 12 months AKRO made 107.61%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months AKRO made 44.60%, while XBI made 17.08%.
Performance Comparison AKRO vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AKRO vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.4% | -6.6% | 120% | 94% |
| US NASDAQ 100 | QQQ | -0.3% | -6.8% | 118% | 94% |
| German DAX 40 | DAX | -0.7% | -3.8% | 107.9% | 77% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.6% | -7.2% | 115.5% | 89% |
| Hongkong Hang Seng | HSI | -1.3% | -5.5% | 98% | 73% |
| India NIFTY 50 | INDA | 1% | -1.8% | 119.5% | 110% |
| Brasil Bovespa | EWZ | 3.8% | -2% | 104.9% | 106% |
AKRO vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1% | -4.3% | 116.7% | 84% |
| Consumer Discretionary | XLY | -1.3% | -6% | 127.7% | 89% |
| Consumer Staples | XLP | 1.7% | -2.5% | 120.9% | 100% |
| Energy | XLE | -3.3% | -6.8% | 127.5% | 106% |
| Financial | XLF | 1.1% | -5.3% | 117.7% | 82% |
| Health Care | XLV | -0.5% | -2.7% | 131.5% | 114% |
| Industrial | XLI | -0.8% | -7.1% | 114.1% | 84% |
| Materials | XLB | -1% | -7.1% | 119.4% | 104% |
| Real Estate | XLRE | -0.1% | -2.5% | 121.5% | 99% |
| Technology | XLK | -0.3% | -9.3% | 114.9% | 96% |
| Utilities | XLU | -0.4% | -5.2% | 116% | 88% |
| Aerospace & Defense | XAR | -1% | -9.5% | 100% | 59% |
| Biotech | XBI | -4% | -5.8% | 130.2% | 119% |
| Homebuilder | XHB | -3.4% | -11.4% | 126.6% | 109% |
| Retail | XRT | -0.3% | -5.9% | 124.8% | 101% |
AKRO vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1% | -5.92% | 134% | 112% |
| Natural Gas | UNG | 1.4% | 3.8% | 146% | 110% |
| Gold | GLD | -0.5% | -2.9% | 102.1% | 69% |
| Silver | SLV | -4.7% | -8.9% | 98% | 85% |
| Copper | CPER | -10.7% | -17.6% | 100.4% | 84% |
AKRO vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.5% | -2.6% | 125.3% | 112% |
| iShares High Yield Corp. Bond | HYG | 0.2% | -3.8% | 123% | 99% |